| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |